TrialAntimicrobial agents and chemotherapy2013

Population pharmacokinetics of escalating doses of caspofungin in a phase II study of patients with invasive aspergillosis.

Gudrun Würthwein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.